BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB is the only ETF that targets 2x the daily returns of the Biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV 8.12% 30.51% 24.65% 18.77% -5.03% 8.69% -2.70% 0.43% 14.52% 04/07/2010
BIB Market Price 8.14% 30.45% 24.49% 18.70% -4.97% 8.65% -2.66% 0.48% 14.52% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 11/05/2025
  • NAV
    $70.23
  • NAV Change
    $+1.93 up caret
  • Market Price
    $70.19
  • Market Price Change
    $+1.90 up caret
  • Trading Volume (M)
    4,190
  • 30-Day Median Bid Ask Spread
    0.29%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 11/05/2025
  • NAV
    $70.23
  • NAV Change
    $+1.93 up caret
  • Market Price
    $70.19
  • Market Price Change
    $+1.90 up caret
  • Trading Volume (M)
    4,190
  • 30-Day Median Bid Ask Spread
    0.29%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2026. Without the fee waiver performance would likely be lower.

Exposures

Index as of 9/30/2025

Holdings

as of 11/05/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
5.08% AMGN AMGEN INC -- $3,463,763.94 10,829 2023607
4.96% GILD GILEAD SCIENCES INC -- $3,380,756.40 27,580 2369174
4.88% VRTX VERTEX PHARMACEUTICALS INC -- $3,322,656.00 7,968 2931034
3.68% REGN REGENERON PHARMACEUTICALS -- $2,505,899.10 3,890 2730190
3.12% ALNY ALNYLAM PHARMACEUTICALS INC -- $2,127,171.20 4,895 B00FWN1
2.32% AZN ASTRAZENECA PLC-SPONS ADR -- $1,582,262.70 19,498 2989044
2.18% INSM INSMED INC -- $1,487,377.92 7,959 2614487
1.41% ARGX ARGENX SE - ADR -- $959,699.55 1,153 BDVLM39
1.24% BIIB BIOGEN INC -- $846,933.60 5,520 2455965
1.14% INCY INCYTE CORP -- $777,212.10 7,353 2471950
1.12% UTHR UNITED THERAPEUTICS CORP -- $762,007.35 1,703 2430412
1.04% ILMN ILLUMINA INC -- $708,560.28 5,787 2613990
0.97% RPRX ROYALTY PHARMA PLC- CL A -- $657,916.34 16,277 BMVP7Y0
0.93% MEDP MEDPACE HOLDINGS INC -- $632,942.17 1,057 BDCBC61
0.84% NBIX NEUROCRINE BIOSCIENCES INC -- $574,102.50 3,734 2623911
0.77% TEM TEMPUS AI INC -- $522,515.52 6,352 BSLSJJ0
0.76% ROIV ROIVANT SCIENCES LTD -- $520,153.76 25,712 BMW4NZ9
0.74% SMMT SUMMIT THERAPEUTICS INC -- $505,399.83 27,969 BMTVQS7
0.73% SNY SANOFI-ADR -- $494,998.00 10,102 2964557
0.69% VTRS VIATRIS INC -- $471,892.75 43,897 BMWS3X9
0.67% ASND ASCENDIS PHARMA A/S - ADR -- $453,045.25 2,291 BV9G6B8
0.66% BBIO BRIDGEBIO PHARMA INC -- $451,026.68 7,198 BK1KWG8
0.66% IONS IONIS PHARMACEUTICALS INC -- $448,229.36 6,002 BDJ0LS6
0.66% GH GUARDANT HEALTH INC -- $446,259.75 4,695 BFXC911
0.61% RVMD REVOLUTION MEDICINES INC -- $417,694.26 7,039 BL71K91
0.60% EXEL EXELIXIS INC -- $409,190.32 10,136 2576941
0.60% ONC BEONE MEDICINES LTD-ADR -- $406,558.35 1,265 BYYWPW6
0.59% MDGL MADRIGAL PHARMACEUTICALS INC -- $399,254.93 839 BD59BS7
0.58% BNTX BIONTECH SE-ADR -- $391,689.41 3,787 BK6H543
0.56% BMRN BIOMARIN PHARMACEUTICAL INC -- $381,744.00 7,230 2437071
0.51% MRNA MODERNA INC -- $345,130.44 14,649 BGSXTS3
0.50% RNA AVIDITY BIOSCIENCES INC -- $338,111.20 4,844 BMWHPY1
0.46% JAZZ JAZZ PHARMACEUTICALS PLC -- $313,410.48 2,284 B4Q5ZN4
0.44% HALO HALOZYME THERAPEUTICS INC -- $300,793.20 4,404 2975098
0.40% MRUS MERUS NV -- $271,072.64 2,848 BZBY005
0.39% CYTK CYTOKINETICS INC -- $266,650.95 4,505 BBBSBJ5
0.37% AXSM AXSOME THERAPEUTICS INC -- $254,825.82 1,878 BYZR4X4
0.37% RYTM RHYTHM PHARMACEUTICALS INC -- $248,774.47 2,501 BF2YWG4
0.34% NUVL NUVALENT INC-A -- $231,145.90 2,510 BMVBZD3
0.32% KRYS KRYSTAL BIOTECH INC -- $217,869.20 1,090 BD6JX35
0.32% PTCT PTC THERAPEUTICS INC -- $214,664.07 2,991 B17VCN9
0.31% ARWR ARROWHEAD PHARMACEUTICALS IN -- $209,813.55 5,205 BYQBFJ8
0.29% PCVX VAXCYTE INC -- $197,084.16 4,888 BKPVGH6
0.29% CRSP CRISPR THERAPEUTICS AG -- $195,133.76 3,424 BDHF4K6
0.28% ALKS ALKERMES PLC -- $193,131.12 6,216 B3P6D26
0.27% ACLX ARCELLX INC -- $182,720.88 2,088 BPCJ1Q2
0.27% PTGX PROTAGONIST THERAPEUTICS INC -- $182,394.96 2,342 BDCBCD8
0.24% AKRO AKERO THERAPEUTICS INC -- $162,798.60 3,012 BK7Y2V9
0.24% -- NEWAMSTERDAM PHARMA CO NV -- $161,688.13 4,241 BP8JSP4
0.24% KYMR KYMERA THERAPEUTICS INC -- $161,223.88 2,692 BMPRZV5
0.23% IMVT IMMUNOVANT INC -- $154,910.40 6,564 BJRFSB7
0.22% CRNX CRINETICS PHARMACEUTICALS IN -- $150,981.50 3,550 BDD19F8
0.22% INDV INDIVIOR PLC -- $150,538.85 4,697 BP0BQQ5
0.21% ACAD ACADIA PHARMACEUTICALS INC -- $141,862.49 6,353 2713317
0.21% LGND LIGAND PHARMACEUTICALS -- $140,500.44 738 2501578
0.20% AMRX AMNEAL PHARMACEUTICALS INC -- $138,234.25 11,825 BFNF1D6
0.20% ADMA ADMA BIOLOGICS INC -- $138,084.08 8,984 B9NSBM2
0.20% VCYT VERACYTE INC -- $136,370.48 2,962 BFTWZY0
0.19% MIRM MIRUM PHARMACEUTICALS INC -- $132,610.28 1,892 BJDX8Y8
0.19% PRAX PRAXIS PRECISION MEDICINES I -- $130,394.88 792 BQ721R4
0.17% RARE ULTRAGENYX PHARMACEUTICAL IN -- $115,656.23 3,629 BJ62Z18
0.17% IRON DISC MEDICINE INC -- $115,597.79 1,309 BMGJZJ8
0.17% GRAL GRAIL INC -- $114,856.48 1,357 BSLSSX7
0.17% TVTX TRAVERE THERAPEUTICS INC -- $113,198.04 3,357 BLFGJD5
0.16% XENE XENON PHARMACEUTICALS INC -- $112,229.98 2,903 BRJ3GY4
0.16% DYN DYNE THERAPEUTICS INC -- $111,961.30 5,357 BN15WD1
0.16% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $110,051.32 4,514 BKX9VD3
0.16% CGON CG ONCOLOGY INC -- $108,983.16 2,871 BRBCSP4
0.16% TARS TARSUS PHARMACEUTICALS INC -- $108,438.00 1,590 BMH5RL1
0.16% FOLD AMICUS THERAPEUTICS INC -- $106,659.14 11,606 B19FQ48
0.15% LEGN LEGEND BIOTECH CORP-ADR -- $101,471.70 3,170 BMX9K07
0.15% SRRK SCHOLAR ROCK HOLDING CORP -- $101,323.80 3,620 BFZQ0L8
0.15% ADPT ADAPTIVE BIOTECHNOLOGIES -- $100,843.47 5,733 BJ5FZ74
0.15% SUPN SUPERNUS PHARMACEUTICALS INC -- $99,449.21 2,111 B72ZBG4
0.15% MLYS MINERALYS THERAPEUTICS INC -- $98,966.40 2,496 BP9N0G0
0.14% IDYA IDEAYA BIOSCIENCES INC -- $97,878.00 3,300 BK0VHF6
0.14% APGE APOGEE THERAPEUTICS INC -- $96,261.20 1,736 BM9HHL5
0.14% APLS APELLIS PHARMACEUTICALS INC -- $94,862.25 4,755 BYTQ6X1
0.13% AGIO AGIOS PHARMACEUTICALS INC -- $88,635.88 2,188 BCBVTX1
0.13% BEAM BEAM THERAPEUTICS INC -- $87,873.63 3,809 BK6L288
0.12% DNLI DENALI THERAPEUTICS INC -- $81,969.45 5,505 BD2B4V0
0.12% CNTA CENTESSA PHARMACEUTICALS-ADR -- $81,342.24 3,612 BLB0YQ9
0.12% RXRX RECURSION PHARMACEUTICALS-A -- $79,801.44 16,089 BM9FJ13
0.11% IBRX IMMUNITYBIO INC -- $76,520.65 35,591 BNSP0B8
0.11% COGT COGENT BIOSCIENCES INC -- $75,834.78 5,259 BLR6XK8
0.11% ANIP ANI PHARMACEUTICALS INC -- $75,670.54 817 BCDWBX6
0.11% GPCR STRUCTURE THERAPEUTICS INC -- $72,279.24 2,244 BQS9486
0.11% AUPH AURINIA PHARMACEUTICALS INC -- $71,628.65 4,957 BFWLC09
0.11% TWST TWIST BIOSCIENCE CORP -- $71,613.44 2,272 BGKG6G7
0.10% OCUL OCULAR THERAPEUTIX INC -- $70,816.31 6,551 BNZB1X8
0.10% VCEL VERICEL CORP -- $70,680.00 1,900 BSBMN89
0.10% MNKD MANNKIND CORP -- $70,017.24 11,554 BF081J4
0.10% AVDL AVADEL PHARMACEUTICALS -- $69,298.80 3,655 BDGMC59
0.10% EWTX EDGEWISE THERAPEUTICS INC -- $69,063.12 3,976 BKY5JZ8
0.10% SRPT SAREPTA THERAPEUTICS INC -- $68,686.93 3,679 B8DPDT7
0.10% HRMY HARMONY BIOSCIENCES HOLDINGS -- $67,904.10 2,166 BKSGZN7
0.09% KNSA KINIKSA PHARMACEUTICALS INTE -- $64,072.18 1,637 BRXB0C0
0.09% JANX JANUX THERAPEUTICS INC -- $62,295.48 2,262 BMFX8Y7
0.09% XERS XERIS BIOPHARMA HOLDINGS INC -- $60,019.47 6,081 BLR7H87
0.09% TERN TERNS PHARMACEUTICALS INC -- $59,936.05 3,295 BMDJ0C9
0.09% TXG 10X GENOMICS INC-CLASS A -- $58,114.92 4,308 BKS3RS7
0.09% VERA VERA THERAPEUTICS INC -- $57,936.40 2,404 BL55460
0.08% ALVO ALVOTECH SA -- $57,510.80 11,785 BPNTJ34
0.08% BCRX BIOCRYST PHARMACEUTICALS INC -- $56,671.68 7,904 2100362
0.08% NTLA INTELLIA THERAPEUTICS INC -- $54,836.37 4,041 BYZM6C2
0.08% ARDX ARDELYX INC -- $53,990.30 9,074 BN89V40
0.08% QURE UNIQURE NV -- $53,839.96 2,066 BJFSR88
0.08% ABCL ABCELLERA BIOLOGICS INC -- $52,776.57 11,253 BL53SR3
0.08% SYRE SPYRE THERAPEUTICS INC -- $51,983.75 2,275 BQBBDY8
0.07% ZYME ZYMEWORKS INC -- $51,081.50 2,830 BPCQZY9
0.07% HROW HARROW INC -- $49,340.06 1,393 BHNDW86
0.07% SNDX SYNDAX PHARMACEUTICALS INC -- $48,969.30 3,243 BN7Q7R7
0.07% NVCR NOVOCURE LTD -- $48,866.49 4,209 BYSS4X4
0.07% TRVI TREVI THERAPEUTICS INC -- $48,784.40 4,585 BJH9ZN0
0.07% WVE WAVE LIFE SCIENCES LTD -- $48,175.68 5,992 BYZG9R0
0.07% STOK STOKE THERAPEUTICS INC -- $47,100.48 2,064 BJQ05Z6
0.07% NVAX NOVAVAX INC -- $47,032.04 6,116 BJDQXG4
0.07% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $46,446.40 1,508 BLCD809
0.07% GMAB GENMAB A/S -SP ADR -- $46,061.82 1,578 BBC9WC7
0.07% DVAX DYNAVAX TECHNOLOGIES CORP -- $45,474.50 4,415 BRJZSK0
0.07% ORIC ORIC PHARMACEUTICALS INC -- $45,261.28 3,656 BKVDFF7
0.07% INBX INHIBRX BIOSCIENCES INC -- $44,919.42 546 BNSP8K3
0.07% PGEN PRECIGEN INC -- $44,767.80 11,220 BKM5C84
0.07% CVAC CUREVAC NV -- $44,684.33 8,479 BN4RD42
0.07% ZLAB ZAI LAB LTD-ADR -- $44,664.80 1,801 BD9GVY0
0.07% AMLX AMYLYX PHARMACEUTICALS INC -- $44,459.92 3,358 BPCK358
0.07% AMPH AMPHASTAR PHARMACEUTICALS IN -- $44,292.50 1,750 BNFWZS4
0.06% INVA INNOVIVA INC -- $43,259.79 2,373 BDDXF67
0.06% RLAY RELAY THERAPEUTICS INC -- $42,522.60 6,492 BN2R582
0.06% COLL COLLEGIUM PHARMACEUTICAL INC -- $42,518.10 1,186 BX7RSN3
0.06% TSHA TAYSHA GENE THERAPIES INC -- $41,396.16 10,272 BNC1BX1
0.06% ELVN ENLIVEN THERAPEUTICS INC -- $41,273.50 2,231 BMFD115
0.06% FTRE FORTREA HOLDINGS INC -- $40,809.25 3,415 BRXYZ57
0.06% SANA SANA BIOTECHNOLOGY INC -- $39,747.36 9,742 BMFJJ97
0.06% GRFS GRIFOLS SA-ADR -- $39,637.59 4,593 B8K7T65
0.06% XNCR XENCOR INC -- $38,583.45 2,685 BGCYWN8
0.06% ORKA ORUKA THERAPEUTICS INC -- $38,534.41 1,411 BKVF0J2
0.06% ANAB ANAPTYSBIO INC -- $37,944.00 1,054 BDRW1L7
0.05% PCRX PACIRA BIOSCIENCES INC -- $36,970.20 1,692 B3X26D8
0.05% CSTL CASTLE BIOSCIENCES INC -- $36,658.44 1,092 BKLCWZ3
0.05% RAPP RAPPORT THERAPEUTICS INC -- $35,957.58 1,374 BR3T9B6
0.05% NRIX NURIX THERAPEUTICS INC -- $35,857.95 2,879 BMVLGP2
0.05% PHAT PHATHOM PHARMACEUTICALS INC -- $35,470.88 2,671 BJLKVS6
0.05% DAWN DAY ONE BIOPHARMACEUTICALS I -- $35,262.12 3,858 BLB0YH0
0.05% SPRY ARS PHARMACEUTICALS INC -- $33,675.05 3,721 BMCR7V2
0.05% URGN UROGEN PHARMA LTD -- $33,638.02 1,742 BZ7PJQ1
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $33,279.59 7,219 BZ0QMB7
0.05% MNMD MIND MEDICINE MINDMED INC -- $33,033.45 2,865 BPQYY97
0.05% KURA KURA ONCOLOGY INC -- $32,493.86 3,269 BYZD465
0.05% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $31,562.05 767 BL95N25
0.05% TNGX TANGO THERAPEUTICS INC -- $31,459.39 4,189 BP2P6L0
0.05% CRMD CORMEDIX INC -- $31,370.76 2,811 BJ0LT31
0.04% TYRA TYRA BIOSCIENCES INC -- $29,728.92 2,006 BMVNDH9
0.04% PRME PRIME MEDICINE INC -- $28,974.00 6,585 BPBJFM7
0.04% GLUE MONTE ROSA THERAPEUTICS INC -- $28,633.06 2,326 BP7KZP7
0.04% EYPT EYEPOINT PHARMACEUTICALS INC -- $28,583.93 2,595 BMGS7L1
0.04% TBPH THERAVANCE BIOPHARMA INC -- $28,345.20 1,896 BMNDK09
0.04% VIR VIR BIOTECHNOLOGY INC -- $28,247.40 5,231 BK4PZ38
0.04% AVBP ARRIVENT BIOPHARMA INC -- $27,989.91 1,527 BMGTLY5
0.04% MESO MESOBLAST LTD- SPON ADR -- $27,630.12 1,778 BQS7491
0.04% AQST AQUESTIVE THERAPEUTICS INC -- $27,336.00 4,556 BYVQJ96
0.04% ATXS ASTRIA THERAPEUTICS INC -- $26,817.50 2,125 BMYRFN8
0.04% ARVN ARVINAS INC -- $26,451.48 2,764 BDZ30Q0
0.04% SVRA SAVARA INC -- $26,227.24 6,508 BYXGN81
0.04% GERN GERON CORP -- $26,185.07 24,023 2370381
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $25,988.82 3,029 BFYQFJ2
0.04% RIGL RIGEL PHARMACEUTICALS INC -- $25,586.60 676 BQD3J33
0.04% PSNL PERSONALIS INC -- $25,576.74 3,339 BJQ0608
0.04% REPL REPLIMUNE GROUP INC -- $25,216.62 2,939 BDDVW37
0.04% IOVA IOVANCE BIOTHERAPEUTICS INC -- $24,663.06 13,626 BF0DMK7
0.04% KROS KEROS THERAPEUTICS INC -- $23,928.85 1,529 BM7V485
0.03% AVXL ANAVEX LIFE SCIENCES CORP -- $23,640.54 3,234 BYTYP72
0.03% ERAS ERASCA INC -- $23,500.40 10,682 BNLYBF3
0.03% LENZ LENZ THERAPEUTICS INC -- $23,058.78 1,074 BQV0J03
0.03% SIGA SIGA TECHNOLOGIES INC -- $22,744.14 2,698 2107437
0.03% ESPR ESPERION THERAPEUTICS INC -- $22,320.48 7,592 BBNBTD2
0.03% RGNX REGENXBIO INC -- $22,082.22 1,902 BZ0G875
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $21,658.65 11,310 B4N8MH9
0.03% ABSI ABSCI CORP -- $21,454.11 5,631 BN94K69
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $21,287.98 2,114 BLFBZ32
0.03% CRVS CORVUS PHARMACEUTICALS INC -- $21,129.18 2,806 BYP80F1
0.03% KALV KALVISTA PHARMACEUTICALS INC -- $20,837.04 1,896 BD06CS0
0.03% PRTA PROTHENA CORP PLC -- $20,817.29 2,027 B91XRN2
0.03% OLMA OLEMA PHARMACEUTICALS INC -- $20,542.80 2,584 BMZ4LN0
0.03% CMPS COMPASS PATHWAYS PLC -- $18,956.97 3,453 BMC3HS7
0.03% LXRX LEXICON PHARMACEUTICALS INC -- $18,882.54 13,683 BWFZX59
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $18,487.09 1,759 BKLXFX5
0.03% HCM HUTCHMED CHINA-ADR -- $18,185.76 1,168 BYXV9H7
0.03% OMER OMEROS CORP -- $17,915.37 2,563 B4NB858
0.02% ALMS ALUMIS INC -- $16,671.36 3,648 BPLQG36
0.02% LXEO LEXEO THERAPEUTICS INC -- $16,670.60 2,033 BQ6C357
0.02% EOLS EVOLUS INC -- $16,589.16 2,436 BDRJH21
0.02% CGEM CULLINAN THERAPEUTICS INC -- $16,264.75 2,225 BM90J52
0.02% GLPG GALAPAGOS NV-SPON ADR -- $16,110.71 539 B292NQ7
0.02% NMRA NEUMORA THERAPEUTICS INC -- $15,979.38 6,099 BN4JN37
0.02% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $15,638.63 5,449 BMCWKZ2
0.02% NGNE NEUROGENE INC -- $14,885.64 537 BS2F741
0.02% DSGN DESIGN THERAPEUTICS INC -- $14,049.75 2,145 BMFK3H6
0.02% RCKT ROCKET PHARMACEUTICALS INC -- $13,492.48 4,064 BDFKQ07
0.02% ACIU AC IMMUNE SA -- $12,968.83 3,781 BZC0D70
0.02% AURA AURA BIOSCIENCES INC -- $12,729.60 2,340 BP81R42
0.02% IRWD IRONWOOD PHARMACEUTICALS INC -- $12,601.02 6,117 B3MZ6K5
0.02% ALT ALTIMMUNE INC -- $12,465.00 3,324 BFY7DC4
0.02% ANNX ANNEXON INC -- $12,458.39 4,139 BMVV9R5
0.02% LYEL LYELL IMMUNOPHARMA INC -- $11,974.96 724 BTNMG41
0.02% AMRN AMARIN CORP PLC -ADR -- $11,620.29 759 BN72KB0
0.02% TECX TECTONIC THERAPEUTIC INC -- $11,573.76 704 BPBPCG8
0.02% SLDB SOLID BIOSCIENCES INC -- $11,522.76 2,932 BQHN6C7
0.02% KYTX KYVERNA THERAPEUTICS INC -- $11,321.55 1,629 BSMLR16
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $11,032.32 1,768 BL5B6Z1
0.02% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $10,741.97 1,741 BKDQKM6
0.02% AUTL AUTOLUS THERAPEUTICS PLC -- $10,459.52 7,552 BFMLGR4
0.02% LRMR LARIMAR THERAPEUTICS INC -- $10,378.06 3,223 BMXNGZ6
0.01% TKNO ALPHA TEKNOVA INC -- $9,974.25 2,015 BP7L561
0.01% TRDA ENTRADA THERAPEUTICS INC -- $9,945.02 1,433 BP81RK8
0.01% VNDA VANDA PHARMACEUTICALS INC -- $9,879.00 2,225 B12W3P6
0.01% AVIR ATEA PHARMACEUTICALS INC -- $9,681.12 2,988 BLN9Z50
0.01% EDIT EDITAS MEDICINE INC -- $9,413.08 3,386 BZ8FPH3
0.01% ALLO ALLOGENE THERAPEUTICS INC -- $9,274.05 8,355 BFZNYB7
0.01% PYXS PYXIS ONCOLOGY INC -- $9,133.76 2,336 BLBR8D5
0.01% VYGR VOYAGER THERAPEUTICS INC -- $8,920.03 2,089 BY7RB53
0.01% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $8,838.72 1,023 BKC9SX3
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $8,790.60 805 B9L5200
0.01% HUMA HUMACYTE INC -- $8,647.80 5,964 BMYTJP4
0.01% FHTX FOGHORN THERAPEUTICS INC -- $8,516.00 2,129 BMF7DT9
0.01% RNAC CARTESIAN THERAPEUTICS INC -- $7,508.93 979 BQB9HM8
0.01% CDXS CODEXIS INC -- $7,307.85 3,399 B5LL2C2
0.01% MXCT MAXCYTE INC -- $6,705.05 4,015 BKMQF66
0.01% OABI OMNIAB INC -- $6,584.93 4,621 BN13S71
0.01% CCCC C4 THERAPEUTICS INC -- $6,353.97 2,681 BKX9NQ0
0.01% PEPG PEPGEN INC -- $5,606.90 1,235 BMTX3D7
0.01% NKTX NKARTA INC -- $5,216.25 2,675 BK80YJ8
0.01% CLYM CLIMB BIO INC -- $4,899.84 2,552 BMW5LX6
0.01% APLT APPLIED THERAPEUTICS INC -- $4,827.01 5,423 BJL38Z1
0.01% ALEC ALECTOR INC -- $4,784.06 3,812 BJ4LDC4
0.01% FATE FATE THERAPEUTICS INC -- $4,733.87 4,343 BCZS820
0.01% TVGN TEVOGEN BIO HOLDINGS INC -- $3,888.68 7,407 BPG5P75
0.01% PLRX PLIANT THERAPEUTICS INC -- $3,791.68 2,312 BMDWW66
0.01% MGNX MACROGENICS INC -- $3,428.64 2,381 BFDV8K0
-- ARTV ARTIVA BIOTHERAPEUTICS INC -- $3,164.80 920 BMF1LJ7
-- STRO SUTRO BIOPHARMA INC -- $3,143.22 3,194 BF12XC2
-- BMEA BIOMEA FUSION INC -- $3,004.28 2,242 BNKF6N0
-- ACRV ACRIVON THERAPEUTICS INC -- $2,405.55 1,185 BP2TPK4
-- TCRX TSCAN THERAPEUTICS INC -- $2,243.90 1,977 BNLYBJ7
-- MRSN MERSANA THERAPEUTICS INC -- $1,598.94 189 BVPKH99
-- OKUR ONKURE THERAPEUTICS INC-A -- $1,452.00 484 BT7KGT6
-- QTTB Q32 BIO INC -- $1,101.79 461 BS2FKQ4
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
37.00% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 25,206,761 -- 4,737 --
28.19% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 19,204,391 -- 3,609 --
24.62% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 16,772,580 -- 3,152 --
19.40% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 13,217,985 -- 2,484 --
17.96% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 12,233,554 -- 2,299 --
9.02% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 6,146,044 -- 1,155 --
-- -- TREASURY BILL -- $4,992,613.05 5,000,000 BMGHP58
-- -- NET OTHER ASSETS (LIABILITIES) -- $19,373,119.40 19,373,119 --

Index

as of 9/30/2025

  • Total Number of Companies251
  • Price/Book Ratio3.78
  • Dividend Yield ( % )0.85
  • Avg. Index Market Capitalization$6.56 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.